← Eichor
Study identifier: NCT07728292 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Safety and Efficacy of Underwater Endoscopic Mucosal Resection for Type I Gastric Neuroendocrine Tumors Measuring 5-9 mm

Condition: Stomach Neuroendocrine Neoplasm  ·  Sponsor: Asian Institute of Gastroenterology, India

PhaseNA
Planned participants60
Who can joinAll sexes, 18 Years to 65 Years
Healthy volunteersNo

About this study

Study objectives: Primary objective: 1.To determine the histologic R0 resection rate of UEMR for type I gastric NETs measuring 5-9 mm. Secondary objectives: To evaluate: 1. En bloc resection rate 2. Immediate and delayed adverse events 3. Procedure time 4. Histologic quality of resection (deep and lateral margins) 5. Residual disease at resection scar on surveillance endoscopy oMetachronous gastric NETs during follow-up

This description comes directly from the study's public registry record.

Talk to the study team

Rajesh Mr Goud, M.Pharmacy  ·  04023378888  ·  rajeshgoud761@gmail.com

Shashavali Dr Maniyar, MD  ·  04023378888  ·  shashimaniyar@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Asian Institute of Gastroenterology/AIG HospitalsHyderabad, Telangana, IndiaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07728292